NOTRELOAD AI
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD (BETA)
  • XY Feed
  • 24-HOUR Pass →
Sign in Subscribe

Crocs Crushes Q4 Expectations: Stock Jumps as Ugly Shoes Make a Comeback

Crocs' latest earnings beat Wall Street forecasts, with strong international growth and cost savings fueling optimism for 2026. Shares surge 19% on better-than-expected results.

Crocs Crushes Q4 Expectations: Stock Jumps as Ugly Shoes Make a Comeback
Credit: Victor J. Blue/Bloomberg
Already have an account? Sign in.
02/12/2026 · 10:31 AM
CROX
/ Read more

Feed↓

Guggenheim Slaps Buy Rating on CRBP: $45 Target Signals Massive Upside
04/29/2026 · 6:52 AM

Guggenheim Slaps Buy Rating on CRBP: $45 Target Signals Massive Upside

Corbus Pharmaceuticals gets Buy rating ($45 target). Drug CRB-701 shows strong cancer results, safer than rivals. Stock down 43% may be opportunity.

/ Subscriber only
Booking Q1 2026 Earnings: Strong Results Despite Middle East Conflict – Guidance Cut for Rest of Year
04/29/2026 · 6:21 AM

Booking Q1 2026 Earnings: Strong Results Despite Middle East Conflict – Guidance Cut for Rest of Year

Booking beat earnings with strong growth, despite Middle East impact; expects modest Q2 and recovery later in 2026.

/ Subscriber only
NXP Semiconductors Crushes Q1 2026 Earnings – Shares Jump on Strong Outlook
Featured/ 04/29/2026 · 6:04 AM

NXP Semiconductors Crushes Q1 2026 Earnings – Shares Jump on Strong Outlook

NXP Semiconductors beat earnings, demand is rising again, and forecasts are strong—shares surged on optimistic outlook.

/ Subscriber only
  • UP↑
  • Terms/Privacy
  • Sign up
  • Sign in
  • Discord
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Invest ↗
  • NOTRELOAD AI
DON'T FALL BEHIND. ©2026
Email address Subscribe